Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of corifollitropin alfa vs daily recombinant FSH for controlled ovarian stimulation in ART
2004-004771-11Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Apr 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of corifollitropin alfa in infertility (2 arms), sponsored by Organon & Co. Primary endpoints: Ongoing pregnancy rate and Number of oocytes retrieved. Started Apr 2006; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on 2004-004771-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004771-11.